Skip to main content

AIM ImmunoTech Inc.

AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000946644

In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.

13F holders, Q2 2026

Institutional positions in AIM ImmunoTech Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
18
0 vs. Q1 2026
Shares held
1.15M
+971.6K (+552.8%) vs. Q1 2026
Total value
$325.6K
+$222.7K (+216.7%) vs. Q1 2026
New holders
4
5 more added
Sold out
4
0 more reduced

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AIM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 18 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 12 institutionsQ3 2025: 15 institutionsQ4 2025: 13 institutionsQ1 2026: 18 institutionsQ2 2026: 18 institutions
Value heldQ2 2026: $325.6K
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $104.8KQ3 2025: $293.9KQ4 2025: $119.8KQ1 2026: $102.8KQ2 2026: $325.6K
Institutions holding AIM and their total value by quarter
QuarterHoldersValue
Q2 202618$325.6K
Q1 202618$102.8K
Q4 202513$119.8K
Q3 202515$293.9K
Q2 202512$104.8K
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding AIM ImmunoTech Inc.; share changes are against Q1 2026.

Institutions holding AIM in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Jane Street Group, LLC807,885$229.4K0.00%+787,838+3,930.0%Added
Virtu Financial LLC124,269$35.0K0.00%+73,374+144.2%Added
Morgan Stanley50,864$14.4K0.00%+50,000+5,787.0%Added
Geode Capital Management, LLC46,003$13.1K0.00%+16,085+53.8%Added
Goldman Sachs Group Inc32,444$9.21K0.00%+32,444New
UBS Group AG28,931$8.22K0.00%+28,930+2,893,000.0%Added
Susquehanna International Group, LLP21,859$6.21K0.00%+21,859New
Vanguard Fiduciary Trust Co17,519$4.97K0.00%00.0%Unchanged
Ground Swell Capital, LLC12,222$3.47K0.00%+12,222New
Tower Research Capital LLC (TRC)4,668$1.33K0.00%00.0%Unchanged
Continuum Advisory, LLC500$1420.00%+500New
Community Bank, N.A.132$360.00%00.0%Unchanged
Harbour Investments, Inc.32$90.00%00.0%Unchanged
Creative Financial Designs Inc30$90.00%00.0%Unchanged
Advisor Group Holdings, Inc.15$30.00%00.0%Unchanged
Hoey Investments, Inc10$30.00%00.0%Unchanged
Farther Finance Advisors, LLC1$00.00%00.0%Unchanged
Intesa Sanpaolo Wealth Management1$00.00%00.0%Unchanged
Steward Partners Investment Advisory, LLC0$00.00%−2−100.0%Sold out
HRT Financial LP0$00.00%−26,032−100.0%Sold out
XTX Topco Ltd0$00.00%−20,590−100.0%Sold out
GWM Advisors LLC0$00.00%−5,000−100.0%Sold out